Substance Use Screening Tools
Substance use screening tools vary by purpose, setting, and depth, ranging from brief population‑level screens to more comprehensive assessments used in clinical care. Widely used instruments support early identification across healthcare, community, and digital settings, while more targeted tools focus on specific substances or populations and others extend into assessment and treatment planning. Below are commonly used screening tools for alcohol, drug, and multi‑substance use to help practitioners, researchers, and policymakers select appropriate options for early detection, brief intervention, and referral to care, with links to original sources where available.
Addiction Severity Index (ASI)
| Accessible data |
Settings |
Primary Substances |
- Clinical assessment and treatment planning
- Monitoring treatment outcomes
|
- Clinical and specialist treatment services
|
|
Global Appraisal of Individual Needs : Short Screener (GAIN-SS)
| Accessible data |
Settings |
Primary Substances |
- Mental health and co-occurring condition screening
- Clinical assessment and treatment planning
|
- Clinical and specialist treatment services
- Community services
|
|
Car, Relax, Alone, Forget, Friends, Trouble (CRAFFT)
| Accessible data |
Settings |
Primary Substances |
- Youth and adolescent risk identification
|
- Schools and adolescent services
|
- Alcohol
- Cannabis
- Multi-substance use
|
Global Appraisal of Individual Needs (Full) (GAIN)
| Accessible data |
Settings |
Primary Substances |
- Clinical assessment and treatment planning
- Monitoring treatment outcomes
- Mental health and co-occurring condition screening
|
- Clinical and specialist treatment services
- Research and epidemiological studies
|
|
Substance Use Brief Screen (SUBS)
| Accessible data |
Settings |
Primary Substances |
- Early detection and brief intervention
|
|
|
Single-Item Screening Questions (SISQ)
| Accessible data |
Settings |
Primary Substances |
- Early detection and brief intervention
|
- General population screening
|
|
European Addiction Severity Index (EuropASI)
| Accessible data |
Settings |
Primary Substances |
- Clinical assessment and treatment planning
- Monitoring treatment outcomes
|
- Clinical and specialist treatment services
- Research and epidemiological studies
|
|
Screening to Brief Intervention (S2BI)
| Accessible data |
Settings |
Primary Substances |
- Youth and adolescent risk identification
- Early detection and brief intervention
|
- Schools and adolescent services
|
- Alcohol
- Cannabis
- Multi-substance use
|
Heaviness of Smoking Index (HIS)
| Accessible data |
Settings |
Primary Substances |
- Tobacco and nicotine dependence assessment
|
- Clinical and specialist treatment services
- Primary care
|
|
Personal Experience Screening Questionnaire (PESQ)
| Accessible data |
Settings |
Primary Substances |
- Youth and adolescent risk identification
|
- Schools and adolescent services
|
|
Risk Assessment Battery (RAB)
| Accessible data |
Settings |
Primary Substances |
- HIV and substance-related behavioural risk
|
- Community services
- High-risk population services
|
- Opioids
- Injection-related risk behaviours
|
Mini International Neuropsychiatric Interview : Substance Use Module (MINI (SU module))
| Accessible data |
Settings |
Primary Substances |
- Mental health and co-occurring condition screening
- Clinical assessment and treatment planning
|
- Clinical and specialist treatment services
|
- Substance use linked to mental health conditions
|
Texas Christian University Drug Screen (TCU Drug Screen)
| Accessible data |
Settings |
Primary Substances |
- Treatment entry screening and triage
- Drug-related crime & justice
|
- Criminal justice settings
|
- Illicit drugs
- Cannabis
- Stimulants
- Opioids
|
Drug Abuse Screening Test (DAST)
| Accessible data |
Settings |
Primary Substances |
- Clinical assessment and treatment planning
|
- Clinical and specialist treatment services
- Research and epidemiological studies
|
- Illicit drugs
- Cannabis
- Stimulants
- Opioids
|